170 likes | 178 Views
This research project aims to boost optic nerve energy to slow the progression of glaucoma. The study investigates the role of mitochondrial function and genetic markers in glaucoma patients, with the goal of developing targeted therapies to improve optic nerve resilience. Current treatments for glaucoma have limitations, and this research aims to identify new approaches to prevent vision loss. Funding for this project is provided by various foundations and research organizations.
E N D
Glaucoma Research Boosting optic nerve energy to slow glaucoma Ian Trounce Principal Investigator CERAWagstaff Fellow RVEEH
The burden of glaucoma • 67 million world-wide • 6 million estimated blind • 7 million out-patient visits in the USA • 150,000 people in Australia • $145 million in direct health costs to Australia • Significant number of Australians with glaucoma are undiagnosed.
Problems with current treatments • Eye pressure lowering is the only treatment proven to be effective in glaucoma • Lowering eye pressure does not always prevent progression • Cannot restore optic nerve tissue once lost
Glaucoma Research Unit • Professor Jonathan Crowston, Principal Investigator • Translational research • Molecular and cellular research • Experimental models • Rodents, rabbits • Clinical research
The cell’s powerhouse: The mitochondrion • ‘Burns’ fuels (food) • Produces energy (ATP) • Produces byproduct‘free radicals’ • Wears out with age
Mitochondria: Power generators of our cells • IN: • Fuel • Carbohydrates • Fats • Proteins • O2 OUT: Energy (ATP) Free radicals CO2 H20 Heat
Mitochondrial DNA - Maternal inheritance
Complex I defect in glaucoma • Link to Parkinson’s disease? • Is it mitochondrial DNA-linked? • New collaboration with • Doug Wallace, Univ. Pennsylvania
Highly energetic nerve cells with long axonsare prone to age-related decline The optic nerve - Glaucoma Dopamine neurons - Parkinson’s disease
Exercise (and fasting) allow old optic nerves to recover from a pressure injury
PhNR change at 1 month P=0016 P=0.0014 3.0 cd.s/m2 2.25 cd.s/m2 IOVS 2013
Summary Mitochondrial energy generation is impaired in some glaucoma patients Diet moderation and exercise improve optic nerve resilience Is this due to increased mitochondrial ‘health’? Genetic analysis of mitochondrial DNA in glaucoma subjects underway Can we identify subjects with genetic markers who may respond to ‘mitochondrial boosting’ therapies?
Can we drive increased Mitochondrial turnover to “recharge the batteries” Dietary restriction Exercise Resveratrol Other drugs e.g. Fibrates Metformin Rapamycin
Thank you Funding Wagstaff Bequest (RVEEH) DHB Foundation Brockhoff Foundation (ANZ Trustees) – Leber Optic Atrophy stem cell study Mason Foundation (ANZ Trustees) – The ‘good’ Alzheimer protein & the ageing eye Michael J. Fox Foundation for Parkinson’s disease – A mitochondrial PD model National Health and Medical Research Council